Never Give Up—Fight Illness With Strength And Science
The article discusses a case report of Filipino workers in Taiwan who developed Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) after taking Metronidazole and Mebendazole. Even when taken weeks apart, these medications can pose serious risks. It emphasizes avoiding self-medication and consulting doctors to prevent severe reactions.
This article explores the potential of the antiparasitic drug mebendazole as a cancer treatment, detailing its dosing, safety profile, and effectiveness.
This article details a case report of patients developing rare, life-threatening Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) after taking Metronidazole and Mebendazole—even when administered six weeks apart.
This article discusses a case report of a man who took mebendazole to treat chemotherapy-resistant metastatic colon cancer—and survived.
This article discusses two studies identifying the potential use of mebendazole for cisplatin -resistant ovarian cancer.
This article is from a 2010 study about how benzimidazoles can be useful in drug-resistant, metastatic prostate cancer.
This article discusses a study that shows the potential effectiveness of using mebendazole for the treatment of triple-negative breast cancer with brain metastasis.
This article is about the potential use of mebendazole for the treatment of triple-negative breast cancer.
